Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome

International Journal of Cardiology

Volumn 152, Issue 2, 2011, Pages 231-236

  Richter, Bernhard ^a   Gwechenberger, Marianne ^a   Socas, Ariel ^a   Zorn, Gerlinde ^a   Albinni, Sulaima ^a   Marx, Manfred ^a   Wolf, Florian ^a   Bergler Klein, Jutta ^a   Loewe, Christian ^a   Bieglmayer, Christian ^a   Binder, Thomas ^a   Wojta, Johann ^a   Gössinger, Heinz D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atrial fibrillation; Catheter ablation; Matrix metalloproteinase 9; The aminoterminal propeptide of type III procollagen; Tissue repair; Transforming growth factor 1

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME REGULATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART SIZE; HUMAN; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIATION ENERGY; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; TISSUE REPAIR; UPREGULATION;

AGE FACTORS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; FEMALE; HEART ATRIA; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; WOUND HEALING;

EID: 80052826760     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.07.021     Document Type: Article

References (36)

1. M. Gharaee-Kermani, and S.H. Phan Role of cytokines and cytokine therapy in wound healing and fibrotic diseases Curr Pharm Des 7 2001 1083 1103 (Pubitemid 32624434)
2. N.G. Frangogiannis The mechanistic basis of infarct healing Antioxid Redox Signal 8 2006 1907 1939 (Pubitemid 46504897)
3. T.J. Badger, R.S. Oakes, and M. Daccarett Temporal left atrial lesion formation after ablation of atrial fibrillation Heart Rhythm 6 2009 161 168
4. D. Ulrich, E.M. Noah, E.R. Burchardt, D. Atkins, and N. Pallua Serum concentration of amino-terminal propeptide of type III procollagen (PIIINP) as a prognostic marker for skin fibrosis after scar correction in burned patients Burns 28 2002 766 771 (Pubitemid 35425421)
5. L.T. Jensen, K. Horslev-Petersen, and P. Toft Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction Circulation 81 1990 52 57 (Pubitemid 20031766)
6. E.E. Creemers, J.P. Cleutjens, J.F. Smits, and M.J. Daemen Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89 2001 201 210 (Pubitemid 34132679)
7. M. Varedi, M.G. Jeschke, E.W. Englander, D.N. Herndon, and R.E. Barrow Serum TGF-beta in thermally injured rats Shock 16 2001 380 382 (Pubitemid 33598214)
8. J.J. Kaden, C.E. Dempfle, and T. Sueselbeck Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction Cardiology 99 2003 140 144 (Pubitemid 36736956)
9. D. Ulrich, E.M. Noah, D. von Heimburg, and N. Pallua TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma Plast Reconstr Surg 111 2003 1423 1431 (Pubitemid 36302270)
10. H. Calkins, J. Brugada, and D.L. Packer HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation Heart Rhythm 4 2007 816 861 (Pubitemid 46850611)
11. B. Kircher, J.A. Abbott, and S. Pau Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography Am Heart J 121 1991 864 871
12. I. Savelieva, and J. Camm Statins and polyunsaturated fatty acids for treatment of atrial fibrillation Nat Clin Pract Cardiovasc Med 5 2008 30 41
13. M. Brueckmann, C. Wolpert, and T. Bertsch Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias J Cardiovasc Electrophysiol 15 2004 686 691 (Pubitemid 38757175)
14. Y. Nakano, S. Niida, and K. Dote Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation J Am Coll Cardiol 43 2004 818 825 (Pubitemid 38296482)
15. A. Kourliouros, I. Savelieva, A. Kiotsekoglou, M. Jahangiri, and J. Camm Current concepts in the pathogenesis of atrial fibrillation Am Heart J 157 2009 243 252
16. P. Reant, S. Lafitte, and P. Jais Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation Circulation 112 2005 2896 2903 (Pubitemid 41613884)
17. H. Muller, S. Noble, and P.F. Keller Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography Europace 10 2008 1073 1078
18. B. Avitall, A. Urbonas, D. Urboniene, S. Millard, and R. Helms Time course of left atrial mechanical recovery after linear lesions: normal sinus rhythm versus a chronic atrial fibrillation dog model J Cardiovasc Electrophysiol 11 2000 1397 1406 (Pubitemid 32016865)
19. V.K. Jayam, J. Dong, and C.R. Vasamreddy Atrial volume reduction following catheter ablation of atrial fibrillation and relation to reduction in pulmonary vein size: an evaluation using magnetic resonance angiography J Interv Card Electrophysiol 13 2005 107 114 (Pubitemid 41175819)
20. L.F. Tops, J.J. Bax, K. Zeppenfeld, M.R. Jongbloed, E.E. van der Wall, and M.J. Schalij Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size Am J Cardiol 97 2006 1220 1222
21. W. Phatharajaree, A. Phrommintikul, and N. Chattipakorn Matrix metalloproteinases and myocardial infarction Can J Cardiol 23 2007 727 733 (Pubitemid 47272296)
22. V. Roldan, F. Marin, and J.R. Gimeno Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy Am Heart J 156 2008 85 91 (Pubitemid 351862294)
23. Z. Nagy, and L. Czirjak Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis Clin Exp Rheumatol 23 2005 165 172 (Pubitemid 40662995)
24. L. Lammi, L. Ryhanen, and E. Lakari Type III and type I procollagen markers in fibrosing alveolitis Am J Respir Crit Care Med 159 1999 818 823 (Pubitemid 29137779)
25. C. Nojgaard, J.S. Johansen, E. Christensen, L.T. Skovgaard, P.A. Price, and U. Becker Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease J Hepatol 39 2003 179 186 (Pubitemid 36920552)
26. L.T. Jensen, and N.B. Host Collagen: scaffold for repair or execution Cardiovasc Res 33 1997 535 539 (Pubitemid 27092854)
27. N.M. Kurdy Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP J Orthop Trauma 14 2000 48 53
28. E.N. Gangemi, D. Gregori, and P. Berchialla Epidemiology and risk factors for pathologic scarring after burn wounds Arch Facial Plast Surg 10 2008 93 102
29. O. Seifert, and U. Mrowietz Keloid scarring: bench and bedside Arch Dermatol Res 301 2009 259 272
30. S.H. Poulsen, N.B. Host, S.E. Jensen, and K. Egstrup Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction Circulation 101 2000 1527 1532 (Pubitemid 30180888)
31. N.B. Host, L.T. Jensen, P.M. Bendixen, S.E. Jensen, O.G. Koldkjaer, and E.E. Simonsen The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction Am J Cardiol 76 1995 869 873
32. F. Ouyang, M. Antz, and S. Ernst Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique Circulation 111 2005 127 135 (Pubitemid 40139722)
33. C.J. Boos, R.A. Anderson, and G.Y. Lip Is atrial fibrillation an inflammatory disorder? Eur Heart J 27 2006 136 149 (Pubitemid 43069029)
34. B. Burstein, and S. Nattel Atrial structural remodeling as an antiarrhythmic target J Cardiovasc Pharmacol 52 2008 4 10
35. T. Liu, L. Li, P. Korantzopoulos, E. Liu, and G. Li Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Int J Cardiol 126 2008 160 170 (Pubitemid 351602110)
36. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150